Forest Can't Nix Mo. Class In Antidepressant Marketing MDL

Law360, New York (January 13, 2014, 5:53 PM EST) -- A Massachusetts federal judge on Friday certified a class of Missouri parents accusing Forest Pharmaceuticals Inc. of misleading them into buying antidepressants for their children that were only approved for adults, but he refused to approve similar proposed classes of New York and Illinois consumers.

U.S. District Judge Nathaniel M. Gorton said allegations similar to those made by the drug buyers, who argued the company’s purported cover-up of studies finding Celexa and Lexapro were ineffective in children denied them the ability to make an informed choice about...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.